Ana V. Ugidos

Founder, CEO, Board Member and Angel Investor

📍 Spain🔄 Updated September 2026💼 4 investments📅 32 years investing🗓 Last invested Jun 2023
VC🌍 Spain
4
Total investments
2
Early stage
0
Mid stage
0
Late stage
32y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Jun 2023
CARDIA by Apolo es la prueba diagnóstica, desarrollada con Inteligencia Artificial, que ayuda a detectar cardiopatías de forma rápida, precisa y ahorrando costes. En base a la imagen en 2D obtenida de una ecocardiograma, CARDIA reconstruye el corazón en 3D, facilitando a los cardiólogos mejorar la toma de decisiones clínicas.
Seed Investor and Board Member
Jun 2023
📢 Únete a la ola de innovación y cultura responsable 📌 Madrid
Seed Investor and Advisor
May 2022
Cloud security has a "fix" problem. Security teams are drowning in alerts, while developers struggle to prioritize remediation. Plexicus bridges this gap by moving beyond simple scanning to automated remediation. We dont just find the risk; we generate the code to fix it. Plexicus is an AI-powered Cloud-Native Application Protection Platform (CNAPP) that automates the identification and remediation of risks across the SDLC. Unlike traditional scanners that only provide visibility, Plexicus uses Generative AI to actively fix misconfigurations in code (IaC), cloud infrastructure, and runtime environments. By unifying ASPM, CSPM, and Container Security into a single engine, Plexicus enables DevSecOps teams to reduce Mean Time to Remediation (MTTR) by 90%. We integrate directly with GitHub, GitLab, and Jenkins to stop risks before they merge. Our Platform: 1) AI-Powered CNAPP: Complete visibility across AWS, Azure, and GCP. 2) Automated Remediation: GenAI agents that draft Pull Requests (PRs) to fix vulnerabilities. 3) ASPM (App Security): Trace runtime threats back to the specific line of code. 4) DevSecOps Integration: Security that works within the developers native workflow.
Board Member
Feb 1994
BTSA is a global company with headquarters in Spain, subsidiary in the United States. With more than 30 years of experience we are one of the leading European manufacturers of Natural Antioxidants and Natural Vitamin E for food, nutraceutical, cosmetics & personal care, and animal nutrition, since 1994. Our customers from more than 40 countries rely on our products and services, which have been developed by our highly qualified team of experts. BTSA’s commitment to the highest quality standards is guaranteed by the main international certificates. For more information, please visit www.btsa.com/en.
Experience · 7 entries
All (7)
Investments (4)
Founder (1)
Board (2)
2024
Patron
Nov 2024
La Fundación Isabel Gemio tiene como objetivo contribuir a acelerar la investigación en las Distrofias Musculares, otras Enfermedades Neuromusculares y Enfermedades Raras, en aquellos aspectos biológicos, fisiopatológicos, genéticos o terapéuticos que puedan incidir en el desarrollo y aplicación de tratamientos curativos a los enfermos, además de fomentar el intercambio de información entre expertos y con los afectados y promover el desarrollo de farmacología.
2023
Seed Investor
Jun 2023
CARDIA by Apolo es la prueba diagnóstica, desarrollada con Inteligencia Artificial, que ayuda a detectar cardiopatías de forma rápida, precisa y ahorrando costes. En base a la imagen en 2D obtenida de una ecocardiograma, CARDIA reconstruye el corazón en 3D, facilitando a los cardiólogos mejorar la toma de decisiones clínicas.
Seed Investor and Board Member
Jun 2023
📢 Únete a la ola de innovación y cultura responsable 📌 Madrid
2022
Seed Investor and Advisor
May 2022
Cloud security has a "fix" problem. Security teams are drowning in alerts, while developers struggle to prioritize remediation. Plexicus bridges this gap by moving beyond simple scanning to automated remediation. We dont just find the risk; we generate the code to fix it. Plexicus is an AI-powered Cloud-Native Application Protection Platform (CNAPP) that automates the identification and remediation of risks across the SDLC. Unlike traditional scanners that only provide visibility, Plexicus uses Generative AI to actively fix misconfigurations in code (IaC), cloud infrastructure, and runtime environments. By unifying ASPM, CSPM, and Container Security into a single engine, Plexicus enables DevSecOps teams to reduce Mean Time to Remediation (MTTR) by 90%. We integrate directly with GitHub, GitLab, and Jenkins to stop risks before they merge. Our Platform: 1) AI-Powered CNAPP: Complete visibility across AWS, Azure, and GCP. 2) Automated Remediation: GenAI agents that draft Pull Requests (PRs) to fix vulnerabilities. 3) ASPM (App Security): Trace runtime threats back to the specific line of code. 4) DevSecOps Integration: Security that works within the developers native workflow.
2015
Owner
Mar 2015
BIOXÁN Neo es una nueva marca de productos de los Laboratorios Bioxán, que nace con la finalidad de proporcionar una mejoría y cuidado real de la piel de todas aquellas personas que están o han estado en tratamiento médico-estético, dermatológico, oncológico, o que tengan la epidermis dañada por factores externos como el sol y la contaminación. También está indicado para quienes deseen una cura de regeneración cutánea con el fin de mejorar su aspecto, desde un punto de vista más estético y saludable. Tras años de estudio e investigaciones precisas con especialistas clínicos y prestigiosos médicos dermatólogos, Laboratorios Bioxán lanza su primera línea de tratamiento regenerador intensivo BIOXÁN Neo, crema regeneradora, biológica y antioxidante.
Show all 7 entries ↓
Investment activity
1994–2023 · 4 investments
199412022120232
Recent (last 2 years)Earlier